DOCSLIB.ORG

The Effect of Ghrelin and Estradiol on Mean Concentration of Thyroid Hormones

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Effect of Ghrelin and Estradiol on Mean Concentration of Thyroid Hormones Int J Endocrinol Metab. 2015 January; 13(1): e17988. DOI: 10.5812/ijem.17988 Research Article Published online 2015 January 1. The Effect of Ghrelin and Estradiol on Mean Concentration of Thyroid Hormones 1 1,* Fatemeh Kordi ; Homayoun Khazali 1Department of Physiology, Shahid Beheshti University, Tehran, IR Iran *Corresponding author : Homayoun Khazali, Department of Physiology, Shahid Beheshti University, Tehran, IR Iran. Tel: +98-9121254041, E-mail: [email protected] Received: ; Revised: ; Accepted: February 2, 2014 August 4, 2014 September 29, 2014 Background: Ghrelin is a novel peptide hormone that has GH releasing activity and also other endocrine and metabolic functions. It can also increase food intake and decrease T3 and T4 concentrations. Several parameters of hypothalamic-pituitary-thyroid (HPT) axis function are modulated by 17β-estradiol (E2). Objectives: The purpose of this study was to investigate the effect of interactions between ghrelin and estradiol (injected via ICV route) on plasma T3 and T4 concentrations in female rats. Materials and Methods: Eighteen Wistar female rats (bodyweight, 200-250 g) were randomly divided into three groups. Group 1 received estradiol, Group 2 received ghrelin and Group 3 received ghrelin and estradiol. Plasma samples were used to assess T3 and T4 concentration by RIA. Results: The results indicated that ghrelin significantly decreased thyroid hormone concentrations, whereas estradiol increased these concentrations. The simultaneous injection of ghrelin and estradiol significantly decreased the inhibitory effect of ghrelin on thyroid hormone concentrations (P < 0.05). Conclusions: According to the results of this study, both ghrelin and estradiol affect the concentration of thyroid hormone but in opposite directions. This difference might be due to different underlying hormonal mechanisms such as HPA and/or HPT axis melanocyte stimulating hormone (MSH) systems could be suggested. Keywords: Ghrelin; Estradiol; Injection 1. Background Ghrelin, as a novel peptide hormone, has the growth- (NPY) pathway and can also decrease the T3 and T4 secre- hormone-releasing activity and also other endocrine tion (6, 13). In addition, studies have shown that ghrelin and metabolic functions (1). Ghrelin is a multifunctional can increase the growth-hormone release (14), gastric- hormone secreted primarily from the stomach (2). It is emptying rate, appetite and body weight (4, 15) and also primarily found as an endogenous ligand for the growth- stimulate the secretion of adrenocorticotropic hormone hormone secretagogue receptor; it is also an appetite stim- and inhibition of thyroid hormone concentrations. The ulating hormone in the regulation of energy homeostasis hypothalamus-pituitary-thyroid axis plays an important (3). It consists of 28 amino acids and the n-octanoylation role in the regulation of metabolism and energy homeo- of serine-3 position in the molecule is necessary for its bio- stasis through thyroid hormones. It has been shown that activity (4). During fasting, ghrelin is secreted by X/A-like different neural, hormonal and environmental factors in- cells of stomach, neurons of hypothalamus and other tis- teract to modulate thyroid hormones secretions. Estradi- β sues (2, 4). Ghrelin can increase the growth-hormone se- ol (E2 or 17 -estradiol, also oestradiol) is a sex hormone. Es- cretions and food intake (5, 6). The full-length preproghre- tradiol is abbreviated E2 as it has two hydroxyl groups in lin is homologous to the promotilin protein classified in its molecular structure (16). In the female, estradiol acts as the motilin family, and is cleaved into the following two a growth hormone for tissue of the reproductive organs, chains: 1) ghrelin and 2) obestatin (7). Ghrelin receptors supporting the lining of the vagina, the cervical glands, are expressed in a wide variety of tissues, including the the endometrium, and the lining of the fallopian tubes. It pituitary, stomach, intestine, pancreas, thymus, gonads, enhances growth of the myometrium. Estradiol appears thyroid, and heart. The diversity of ghrelin receptor lo- necessary to maintain oocytes in the ovary. The central cations suggests ghrelin has the diverse biological func- event in female reproduction is the surge release of lu- tions (8). It decreases energy expenditure and suppresses teinizing hormone from anterior pituitary gonadotroph TSH secretion. Previous studies have shown that ghrelin (17). These cells are controlled by a network of gonadotro- decreases the activity of hypothalamus-pituitary-thyroid ping hormone neurons that project to the median emi- axis (6, 9-13). It is also proved that ghrelin can increase the nence where they make a neurohemal contact with portal appetite via agouti-related protein and neuropeptide Y capillaries serving the anterior pituitary (18-20) The high- Copyright © 2015, Research Institute For Endocrine Sciences and Iran Endocrine Society. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate- rial just in noncommercial usages, provided the original work is properly cited. Kordi F et al. est level of the receptors was found in the periventricular taxic frame and a 22-gauge stainless steel cannula was nucleus of the preoptic area, while low but detectable lev- implanted into the third ventricle. The cannula was se- els of the receptors were found in such limbic regions as cured to the skull with three stainless steel screws and the nucleus of the diagonal band, the olfactory tubercle dental cement. The animals were kept in the individual and the cingulate cortex (18). Regions that were devoid of cages and habituated by handling every day to minimize detectable receptor included the medial septum, the pari- the stress of surgery. After a one-week recovery period, in etal cortex, and the ventral thalamus. Menopause marks the previous paper, the effective dose of ghrelin admin- the end of the reproductive life span of women and is istered IV was 5 nmol (24) and the effective dose of estra- characterized by a dramatic drop of circulating estrogen diol was 50 µg /mL (18) (Ghrelin and estradiol provided by hormone replacement therapy has been successfully used Ana Spec Co, USA). Ghrelin was dissolved in 100 µL of 0.9% to treat the symptoms of menopause because estrogen saline and estradiol dissolved in olive oil. Ghrelin and es- has a strong suppressive effect on rat (19). Estrogen and tradiol were injected by a 27-gauge stainless steel injector, androgen administration modulate the pituitary-thyroid which connected to 10 µL Hamilton micro syringe (model axis through alterations in thyroid hormone-binding 9435, Australia) by PE-20 tubing. globulin metabolism, but the effect of sex steroids on ex- trathyroidal thyroxine (T4) to triiodothyronine (T3) con- 3.3. Blood Collection version in rats are unknown. It has been suggested that the female rat steroids stimulate thyroid growth (20). Sev- Blood samples were collected from tail vein and imme- enteen beta-estradiol, the major estrogen in the body, acts diately centrifuged at 3500 rpm and the plasma samples via estrogen receptors present in the nucleus of the cell were stored at -20 °C until the T3 and T4 concentrations (21, 22). Hypothalamus-pituitary-thyroid axis plays an im- were assayed. At the end of the experimentation, the portant role in the regulation of metabolism and energy blood samples were collected daily starting from one day homeostasis through thyroid hormones (22, 23). There is before the injection until 30, 360,720, 1440 minutes and no evidence to support the effect of estradiol on the thy- 4 days after the injection. Heparin was used in samples to roid axis. This study was designed to examine the effect of prevent clotting. ghrelin and estradiol on mean plasma T3 and T4 concen- 3.4. Brain Removal trations. In the present study, the effect of an interaction between ghrelin and estradiol on thyroid axis activity was The animal brains were removed and kept in formalin investigated for the first time. (10%) for two weeks. The correct ICV cannulae placement 2. Objectives was confirmed histologically. Only those animals with properly positioned cannulae were included in the data The purpose of this study was to examine the effect of analysis. the interaction between ghrelin and estradiol (injected via ICV route) on mean plasma T3 and T4 concentrations 3.5. Hormone Assay in female rats. The mean plasma T3 and T4 concentrations were mea- 3. Materials and Methods sured. Plasma T3 and T4 concentrations were measured by T3 and T4 Kits and the method of a homologus double- 3.1. Experimental Design antibody radioimmunoassay. Sensitivities of the T3 and T4 assays were 0.0046 and 0.54 mg/dL, respectively. Eighteen adult female wistar rats weighing 200-250 g were randomly divided into three groups (provided by 3.6. Statistical Analysis the center of neuroscience research of Shahid Beheshti SPSS version19 (IBM, USA, 2010) was used for statisti- University) were housed individually in cages under cal analysis. The one-sample Shapiro-Wilk test was per- the controlled temperature (22 ± 2) and light (12 h light/ formed to determine normal distribution of the data. dark cycle). They had free access to food and water all the Results were expressed as mean ± SD. Data were analyzed time. Eighteen wistar female rats (200-250 g/BW) were using repeated-measures ANOVA. P< 0.05 was considered randomly divided into three groups. Groups 1 received significant statistically. ghrelin, group 2 received estradiol and group 3 received ghrelin and estradiol (via third ventricle). Animal surgery 4. Results procedures and handling were carried out as previously described. Animals were anesthetized by IP injection of 4.1. Effects of Ghrelin Injection a mixture of ketamine and xylazine (100 mg/kg BW ket- amine + 15 mg/kg BW xylazine; Alfasan Co., Holland). Intraventricular injection of 5 nmol ghrelin significant- 3.2. Third Ventricle Cannulation ly decreased plasma levels of T3 and T4 at 30 minutes af- ter injection (P < 0.
Load more

Recommended publications
  • Adipokines in Breast Milk: an Update Gönül Çatlı1, Nihal Olgaç Dündar2, Bumin Nuri Dündar3
    J Clin Res Pediatr Endocrinol 2014;6(4):192-201 DO I: 10.4274/jcrpe.1531 Review Adipokines in Breast Milk: An Update Gönül Çatlı1, Nihal Olgaç Dündar2, Bumin Nuri Dündar3 1Tepecik Training and Research Hospital, Clinic of Pediatric Endocrinology, İzmir, Turkey 2Katip Çelebi University Faculty of Medicine, Department of Pediatric Neurology, İzmir, Turkey 3Katip Çelebi University Faculty of Medicine, Department of Pediatric Endocrinology, İzmir, Turkey Introduction Human breast milk comprises a variety of nutrients, cytokines, peptides, enzymes, cells, immunoglobulins, proteins and steroids specially suited to meet the needs of newborn infants (1,2). Breast milk has benefits on preventing metabolic disorders and chronic diseases and is referred to as “functional food” due to its roles other than nutrition (1,2). It contains 87-90% water and is the main source of water for newborns (3,4,5). In addition, several peptide/protein hormones have recently been identified in human breast milk, including leptin, adiponectin, resistin, obestatin, nesfatin, irisin, adropin, copeptin, ghrelin, pituitary adenylate cyclase-activating polypeptide, apelins, motilin and cholecystokinin (6,7). These breast milk hormones may transiently regulate the activities of various tissues, including endocrine organs until the endocrine system of the neonate begins to function (6). Some of these peptides are secreted in biologically active forms (3). Leptin, ghrelin, insulin, adiponectin, obestatin, resistin, epidermal growth factor, platelet-derived growth factor and insulin-like growth factor 1 are bioactive substances that play roles in energy intake and regulation of body composition (3). However, functions of some ABS TRACT of these peptides in neonatal development are still unknown Epidemiological surveys indicate that nutrition in infancy is implicated in the (4).
    [Show full text]
  • Searching for Novel Peptide Hormones in the Human Genome Olivier Mirabeau
    Searching for novel peptide hormones in the human genome Olivier Mirabeau To cite this version: Olivier Mirabeau. Searching for novel peptide hormones in the human genome. Life Sciences [q-bio]. Université Montpellier II - Sciences et Techniques du Languedoc, 2008. English. tel-00340710 HAL Id: tel-00340710 https://tel.archives-ouvertes.fr/tel-00340710 Submitted on 21 Nov 2008 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. UNIVERSITE MONTPELLIER II SCIENCES ET TECHNIQUES DU LANGUEDOC THESE pour obtenir le grade de DOCTEUR DE L'UNIVERSITE MONTPELLIER II Discipline : Biologie Informatique Ecole Doctorale : Sciences chimiques et biologiques pour la santé Formation doctorale : Biologie-Santé Recherche de nouvelles hormones peptidiques codées par le génome humain par Olivier Mirabeau présentée et soutenue publiquement le 30 janvier 2008 JURY M. Hubert Vaudry Rapporteur M. Jean-Philippe Vert Rapporteur Mme Nadia Rosenthal Examinatrice M. Jean Martinez Président M. Olivier Gascuel Directeur M. Cornelius Gross Examinateur Résumé Résumé Cette thèse porte sur la découverte de gènes humains non caractérisés codant pour des précurseurs à hormones peptidiques. Les hormones peptidiques (PH) ont un rôle important dans la plupart des processus physiologiques du corps humain.
    [Show full text]
  • Endocrine Implications of Obesity and Bariatric Surgery
    Praca Poglądowa/review Endokrynologia Polska DOI: 10.5603/EP.2018.0059 Tom/Volume 69; Numer/Number 5/2018 ISSN 0423–104X Endocrine implications of obesity and bariatric surgery Michał Dyaczyński1, Colin Guy Scanes2, Helena Koziec3, Krystyna Pierzchała-Koziec4 1Siemianowice Śląskie Municipal Hospital, Department of General Surgery, Siemianowice Śląskie, Poland 2Centre in Excellence in Poultry Science, University of Arkansas, Fayetteville, Fayetteville, Arkansas, USA 3Josef Babinski Clinical Hospital in Krakow, Poland 4Department of Animal Physiology and Endocrinology, University of Agriculture in Krakow, Poland Abstract Obesity is a highly prevalent disease in the world associated with the disorders of endocrine system. Recently, it may be concluded that the only effective treatment of obesity remains bariatric surgery. The aim of the review was to compare the concepts of appetite hormonal regulation, reasons of obesity development and bariatric pro- cedures published over the last decade. The reviewed publications had been chosen on the base on: 1. reasons and endocrine consequences of obesity; 2. development of surgery methods from the first bariatric to present and future less aggressive procedures; 3. impact of surgery on the endocrine status of patient. The most serious endocrine disturbances during obesity are dysfunctions of hypothalamic circuits responsible for appetite regulation, insulin resistance, changes in hormones activity and abnormal activity of adipocytes hormones. The currently recommended bariatric surgeries are Roux-en-Y gastric bypass, sleeve gastrectomy and adjustable gastric banding. Bariatric surgical procedures, particularly com- bination of restrictive and malabsorptive, decrease the body weight and eliminate several but not all components of metabolic syndrome. Conclusions: 1. Hunger and satiety are mediated by an interplay of nervous and endocrine signals.
    [Show full text]
  • What Is Pancreatic Polypeptide and What Does It Do?
    What is Pancreatic Polypeptide and what does it do? This document aims to evaluate current understanding of pancreatic polypeptide (PP), a gut hormone with several functions contributing towards the maintenance of energy balance. Successful regulation of energy homeostasis requires sophisticated bidirectional communication between the gastrointestinal tract and central nervous system (CNS; Williams et al. 2000). The coordinated release of numerous gastrointestinal hormones promotes optimal digestion and nutrient absorption (Chaudhri et al., 2008) whilst modulating appetite, meal termination, energy expenditure and metabolism (Suzuki, Jayasena & Bloom, 2011). The Discovery of a Peptide Kimmel et al. (1968) discovered PP whilst purifying insulin from chicken pancreas (Adrian et al., 1976). Subsequent to extraction of avian pancreatic polypeptide (aPP), mammalian homologues bovine (bPP), porcine (pPP), ovine (oPP) and human (hPP), were isolated by Lin and Chance (Kimmel, Hayden & Pollock, 1975). Following extensive observation, various features of this novel peptide witnessed its eventual classification as a hormone (Schwartz, 1983). Molecular Structure PP is a member of the NPY family including neuropeptide Y (NPY) and peptide YY (PYY; Holzer, Reichmann & Farzi, 2012). These biologically active peptides are characterized by a single chain of 36-amino acids and exhibit the same ‘PP-fold’ structure; a hair-pin U-shaped molecule (Suzuki et al., 2011). PP has a molecular weight of 4,240 Da and an isoelectric point between pH6 and 7 (Kimmel et al., 1975), thus carries no electrical charge at neutral pH. Synthesis Like many peptide hormones, PP is derived from a larger precursor of 10,432 Da (Leiter, Keutmann & Goodman, 1984). Isolation of a cDNA construct, synthesized from hPP mRNA, proposed that this precursor, pre-propancreatic polypeptide, comprised 95 residues (Boel et al., 1984) and is processed to produce three products (Leiter et al., 1985); PP, an icosapeptide containing 20-amino acids and a signal peptide (Boel et al., 1984).
    [Show full text]
  • Anorexia Nervosa: a Unified Neurological Perspective Tasneem Fatema Hasan, Hunaid Hasan 
    Int. J. Med. Sci. 2011, 8 679 Ivyspring International Publisher International Journal of Medical Sciences 2011; 8(8):679-703 Review Anorexia Nervosa: A Unified Neurological Perspective Tasneem Fatema Hasan, Hunaid Hasan Mahatma Gandhi Mission’s Medical College, Aurangabad, Maharashtra, India Corresponding author: [email protected] or [email protected]. 1345 Daniel Creek Road, Mississau- ga, Ontario, L5V1V3, Canada. © Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/ licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. Received: 2011.05.03; Accepted: 2011.09.19; Published: 2011.10.22 Abstract The roles of corticotrophin-releasing factor (CRF), opioid peptides, leptin and ghrelin in anorexia nervosa (AN) were discussed in this paper. CRF is the key mediator of the hypo- thalamo-pituitary-adrenal (HPA) axis and also acts at various other parts of the brain, such as the limbic system and the peripheral nervous system. CRF action is mediated through the CRF1 and CRF2 receptors, with both HPA axis-dependent and HPA axis-independent ac- tions, where the latter shows nil involvement of the autonomic nervous system. CRF1 re- ceptors mediate both the HPA axis-dependent and independent pathways through CRF, while the CRF2 receptors exclusively mediate the HPA axis-independent pathways through uro- cortin. Opioid peptides are involved in the adaptation and regulation of energy intake and utilization through reward-related behavior. Opioids play a role in the addictive component of AN, as described by the “auto-addiction opioids theory”.
    [Show full text]
  • Maternal Smoking and Infantile Gastrointestinal Dysregulation: the Case of Colic
    Maternal Smoking and Infantile Gastrointestinal Dysregulation: The Case of Colic Edmond D. Shenassa, ScD*‡, and Mary-Jean Brown, ScD, RN§ ABSTRACT. Background. Infants’ healthy growth intestinal motilin levels and (2) higher-than-average lev- and development are predicated, in part, on regular func- els of motilin are linked to elevated risks of IC. Although tioning of the gastrointestinal (GI) tract. In the first 6 these findings from disparate fields suggest a physio- months of life, infants typically double their birth logic mechanism linking maternal smoking with IC, the weights. During this period of intense growth, the GI entire chain of events has not been examined in a single tract needs to be highly active and to function optimally. cohort. A prospective study, begun in pregnancy and Identifying modifiable causes of GI tract dysregulation continuing through the first 4 months of life, could pro- is important for understanding the pathophysiologic pro- vide definitive evidence linking these disparate lines of cesses of such dysregulation, for identifying effective research. Key points for such a study are considered. and efficient interventions, and for developing early pre- Conclusions. New epidemiologic evidence suggests vention and health promotion strategies. One such mod- that exposure to cigarette smoke and its metabolites may ifiable cause seems to be maternal smoking, both during be linked to IC. Moreover, studies of the GI system and after pregnancy. provide corroborating evidence that suggests that (1) Purpose. This article brings together information that smoking is linked to increased plasma and intestinal strongly suggests that infants’ exposure to tobacco smoke motilin levels and (2) higher-than-average intestinal mo- is linked to elevated blood motilin levels, which in turn tilin levels are linked to elevated risks of IC.
    [Show full text]
  • Review Article Breast Milk Hormones and Their Protective Effect on Obesity
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central Hindawi Publishing Corporation International Journal of Pediatric Endocrinology Volume 2009, Article ID 327505, 8 pages doi:10.1155/2009/327505 Review Article Breast Milk Hormones and Their Protective Effect on Obesity Francesco Savino, Stefania A. Liguori, Maria F. Fissore, and Roberto Oggero Department of Pediatrics, Regina Margherita Children’s Hospital, University of Turin, 10126 Turin, Italy Correspondence should be addressed to Francesco Savino, [email protected] Received 8 May 2009; Accepted 27 September 2009 Recommended by Jesus Argente Data accumulated over recent years have significantly advanced our understanding of growth factors, cytokines, and hormones in breast milk. Here we deal with leptin, adiponectin, IGF-I, ghrelin, and the more recently discovered hormones, obestatin, and resistin, which are present in breast milk and involved in food intake regulation and energy balance. Little is known about these compounds in infant milk formulas. Nutrition in infancy has been implicated in the long-term tendency to obesity, and a longer duration of breastfeeding appears to protect against its development. Diet-related differences in serum leptin and ghrelin values in infancy might explain anthropometric differences and differences in dietary habits between breast-fed and formula-fed infants also later in life. However, there are still gaps in our understanding of how hormones present in breast milk affect children. Here we examine the data related to hormones contained in mother’s milk and their potential protective effect on subsequent obesity. Copyright © 2009 Francesco Savino et al.
    [Show full text]
  • Corticotropin-Releasing Factor and the Brain-Gut Motor Response to Stress
    Color profile: Generic offset separations profile Black 133 lpi at 45 degrees GUT DYSFUNCTION IN IBS Corticotropin-releasing factor and the brain-gut motor response to stress 1 1 1 2 Yvette Taché PhD , Vicente Martinez DVM PhD , Mulugeta Million DVM PhD , Jean Rivier PhD Y Taché, V Martinez, M Million, J Rivier. Corticotropin- La corticolibérine (CRF) et la réponse de l’axe releasing factor and the brain-gut motor response to stress. Can J Gastroenterol 1999;13(Suppl A):18A-25A. The character- cerveau-intestin au stress ization of corticotropin-releasing factor (CRF) and CRF recep- RÉSUMÉ : La caractérisation de la corticolibérine (ou CRF, pour cortico- tors, and the development of specific CRF receptor antagonists tropin-releasing factor) et de ses récepteurs, ainsi que le développement selective for the receptor subtypes have paved the way to the un- d’antagonistes spécifiques du CRF manifestant une sélectivité à l’endroit derstanding of the biochemical coding of stress-related alterations de certains sous-types des récepteurs, ont pavé la voie à une meilleure com- of gut motor function. Reports have consistently established that préhension de l’encodage biochimique de la dysmotilité intestinale liée au central administration of CRF acts in the brain to inhibit gastric stress. Les rapports ont toujours confirmé que l’administration centrale de emptying while stimulating colonic motor function through mod- CRF agit sur le cerveau pour inhiber la vidange gastrique tout en stimulant ulation of the vagal and sacral parasympathetic outflow in rodents. la motricité du côlon par l’entremise d’une modulation de l’influx vagal et Endogenous CRF in the brain plays a role in mediating various parasympathique sacré chez le rat.
    [Show full text]
  • Views of the NIDA, NINDS Or the National Summed Across the Three Auditory Forebrain Lobule Sec- Institutes of Health
    Xie et al. BMC Biology 2010, 8:28 http://www.biomedcentral.com/1741-7007/8/28 RESEARCH ARTICLE Open Access The zebra finch neuropeptidome: prediction, detection and expression Fang Xie1, Sarah E London2,6, Bruce R Southey1,3, Suresh P Annangudi1,6, Andinet Amare1, Sandra L Rodriguez-Zas2,3,5, David F Clayton2,4,5,6, Jonathan V Sweedler1,2,5,6* Abstract Background: Among songbirds, the zebra finch (Taeniopygia guttata) is an excellent model system for investigating the neural mechanisms underlying complex behaviours such as vocal communication, learning and social interactions. Neuropeptides and peptide hormones are cell-to-cell signalling molecules known to mediate similar behaviours in other animals. However, in the zebra finch, this information is limited. With the newly-released zebra finch genome as a foundation, we combined bioinformatics, mass-spectrometry (MS)-enabled peptidomics and molecular techniques to identify the complete suite of neuropeptide prohormones and final peptide products and their distributions. Results: Complementary bioinformatic resources were integrated to survey the zebra finch genome, identifying 70 putative prohormones. Ninety peptides derived from 24 predicted prohormones were characterized using several MS platforms; tandem MS confirmed a majority of the sequences. Most of the peptides described here were not known in the zebra finch or other avian species, although homologous prohormones exist in the chicken genome. Among the zebra finch peptides discovered were several unique vasoactive intestinal and adenylate cyclase activating polypeptide 1 peptides created by cleavage at sites previously unreported in mammalian prohormones. MS-based profiling of brain areas required for singing detected 13 peptides within one brain nucleus, HVC; in situ hybridization detected 13 of the 15 prohormone genes examined within at least one major song control nucleus.
    [Show full text]
  • Responses of Python Gastrointestinal Regulatory Peptides to Feeding
    Responses of python gastrointestinal regulatory peptides to feeding Stephen M. Secor*†‡, Drew Fehsenfeld§, Jared Diamond*, and Thomas E. Adrian§¶ *Department of Physiology, University of California School of Medicine, Los Angeles, CA 90095-1751; and §Department of Biomedical Sciences, Creighton University School of Medicine, Omaha, NE 68178 Contributed by Jared Diamond, October 3, 2001 In the Burmese python (Python molurus), the rapid up-regulation intestine begins to respond (in function and morphology) to of gastrointestinal (GI) function and morphology after feeding, and feeding within a few hours, before any of the ingested meal has subsequent down-regulation on completing digestion, are ex- reached the intestine (5). (ii) Python intestinal segments that pected to be mediated by GI hormones and neuropeptides. Hence, have been surgically isolated from contact with intestinal nutri- we examined postfeeding changes in plasma and tissue concen- ents but still retain their neurovascular supply continue to trations of 11 GI hormones and neuropeptides in the python. up-regulate nutrient transport after feeding (6). (iii) Eight Circulating levels of cholecystokinin (CCK), glucose-dependent in- python GI peptides have been identified and sequenced (8, 9). sulinotropic peptide (GIP), glucagon, and neurotensin increase by Hence, the python model offers an attractive alternative to respective factors of 25-, 6-, 6-, and 3.3-fold within 24 h after mammals for resolving uncertainties about actions of GI hor- feeding. In digesting pythons, the regulatory peptides neuroten- mones and neuropeptides. sin, somatostatin, motilin, and vasoactive intestinal peptide occur In this article, we describe plasma concentrations of four largely in the stomach, GIP and glucagon in the pancreas, and CCK peptides [cholecystokinin (CCK), glucose-dependent insulino- and substance P in the small intestine.
    [Show full text]
  • Evolutionarily Conserved TRH Neuropeptide Pathway Regulates
    Evolutionarily conserved TRH neuropeptide pathway PNAS PLUS regulates growth in Caenorhabditis elegans Elien Van Sinaya, Olivier Mirabeaub, Geert Depuydta, Matthias Boris Van Hiela, Katleen Peymena, Jan Watteynea, Sven Zelsa, Liliane Schoofsa,1, and Isabel Beetsa,1 aFunctional Genomics and Proteomics Group, Department of Biology, KU Leuven, 3000 Leuven, Belgium; and bGenetics and Biology of Cancers Unit, Institut Curie, INSERM U830, Paris Sciences et Lettres Research University, Paris 75005, France Edited by Iva Greenwald, Columbia University, New York, NY, and approved April 7, 2017 (received for review October 20, 2016) In vertebrates thyrotropin-releasing hormone (TRH) is a highly con- THs likely originated early in deuterostomian evolution (15), the served neuropeptide that exerts the hormonal control of thyroid- prime role of TRH in controlling TH levels seems to have evolved stimulating hormone (TSH) levels as well as neuromodulatory more recently in vertebrates. In fish and amphibians, TRH has no or functions. However, a functional equivalent in protostomian ani- only a minor effect on the production of TSH but allows the secretion mals remains unknown, although TRH receptors are conserved in of growth hormone (GH), prolactin (PRL), and α-melanocyte– proto- and deuterostomians. Here we identify a TRH-like neuropep- stimulating hormone (α-MSH) (9, 16). In nonmammalian vertebrates tide precursor in Caenorhabditis elegans that belongs to a bilaterian corticotropin-releasing hormone (CRH), a prime regulator of stress family of TRH precursors. Using CRISPR/Cas9 and RNAi reverse genetics, responses, is a potent inducer of TSH secretion (16). These effects we show that TRH-like neuropeptides, through the activation of their raise the question as to what the ancient function of TRH might have receptor TRHR-1, promote growth in C.
    [Show full text]
  • Release of Motilin by Oral and Intravenous Nutrients in Man
    Gut: first published as 10.1136/gut.20.2.102 on 1 February 1979. Downloaded from Gut, 1979, 20, 102-106 Release of motilin by oral and intravenous nutrients in man N. D. CHRISTOFIDES, S. R. BLOOM, H. S. BESTERMAN, T. E. ADRIAN, AND M. A. GHATEI From the Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London SUMMARY Motilin is a hormonal peptide found in the duodenum and jejunum which potently influences gastrointestinal tract motility. Its role in human physiology is not yet established. After a standard hospital lunch the plasma concentration ofmotilin showed a small, transient, but significant rise in 28 healthy subjects. Individual food components either stimulated (oral fat) or suppressed release (oral glucose). Plasma motilin levels were, in addition, altered to an equal extent by intra- venous nutrients, with glucose and amino acids suppressing release, and intravenous fat causing a significant rise in plasma concentration. These results demonstrate a consistent response to food stimuli, whether oral or intravenous. The release mechanism appears to be complicated and after a balanced meal, containing food components which both stimulate and suppress release, there is only a small net change. The mechanisms involved in the release of plasma ORAL NUTRITION http://gut.bmj.com/ motilin in man have not been elucidated. Recently it 1. A standard meal containing two boiled eggs, has been shown that instillation of acid in the duo- orange juice, buttered toast and marmalade, com- denum results in a sharp rise of plasma motilin posed of 66 g carbohydrate, 18 g protein, and 22 g (Mitznegg et al., 1976).
    [Show full text]